Profound Medical (PROF) Short term Debt (2018 - 2026)

Profound Medical (PROF) posted quarterly Short term Debt of $4.5 million for Q1 2026, up 0.51% quarter-over-quarter from $4.5 million in Q3 2025.

Profound Medical (PROF) Short term Debt (2018 - 2026) Analysis & Trends

Profound Medical's Short term Debt history runs 7 years deep, the most recent figure standing at $4.5 million for Q1 2026.

In Q1 2026, Short term Debt changed N/A year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (changed N/A YoY), while the FY2024 annual figure was $1.7 million, down 17.44% from the prior year.
Short term Debt for Q1 2026 stood at $4.5 million, up from $4.5 million in the prior quarter.
The five-year high for Short term Debt was $4.5 million in Q1 2026, with the low at $523000.0 in Q4 2022.
The 5-year median for Short term Debt is $2.1 million (2023), against an average of $2.7 million.
The sharpest annual moves came in 2023 and 2024: Short term Debt surged 302.29% in 2023, then retreated 17.44% in 2024.
Profound Medical's Short term Debt stood at $523000.0 in 2022, then soared by 302.29% to $2.1 million in 2023, then dropped by 17.44% to $1.7 million in 2024, then surged by 157.92% to $4.5 million in 2025, then grew by 0.51% to $4.5 million in 2026.
Business Quant data shows PROF's Short term Debt at $4.5 million in Q1 2026, $4.5 million in Q3 2025, and $1.7 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Profound Medical	241.00 Mn	202.73 Mn	1.95 Mn

Download Data